XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.81

0.0%

Nov 24 3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (7860)	11/27/1998 8:10:00 PM
From: Bluegreen	Read Replies (1) of 17367

But George the press release was severely tainted by mention of wanting to move domicile to Bermuda in my opinion. I didn't see ENMD or GERN with anticipation type of press release or story followed by announcement of offshore domicile translocation. When you take Xoma's history and add wanted change of domicile offshore, it would take immense amount of strong anticipatory possibilities to counter, in my opinion. Now, George, getting out of paying ANY type of US taxes on ANY revenue stream is getting out of paying taxes, hence my thinking it might be cheesy and bad karma after Uncle Sam gives you orphan drug status especially of a drug you are wanting approval of to treat young ones suffering from Meningo. Which brings me to hope the FDA does not frown on Biotechs that want to run to Bermuda for tax protection especially during approval processes. Don't take all of this seriously. Just my thinking and opinions while some of us anticipate POSSIBLE approval of Neuprex.<g>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next